Ivermectin is a Nobel Prize winning drug. It has been called a wonder drug. It is used by over 2.2 Billion people in the world to combat occasional parasites, and is used constantly by about 700 million people to prevent river blindness. The people that use Ivermectin constantly have about 1/10 as many covid case and death rates as people who don’t use Ivermectin. You can see the evidence here.
No it is not that NIH doesn’t know. Their scientists know, but their hands are tied by politics. The decisions are based by politics. But they are trying to get the story out. Check their official library of appoived articles. The firstlist is on Ivermectin and cancer (source https://search.nih.gov/search?affiliate=nih&query=ivermectin+cancer)
Ivermectin, a potential anticancer drug derived from an …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer …
Ivermectin has New Application in Inhibiting Colorectal …
pubmed.ncbi.nlm.nih.gov/34483925/
Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown …
The multitargeted drug ivermectin: from an antiparasitic …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835698/
Ivermectin interacts with several targets including the multidrug resistance protein (MDR), the Akt/mTOR and WNT-TCF pathways, the purinergic …
Ivermectin has New Application in Inhibiting Colorectal …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415024/
Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown …
Anti-parasite drug ivermectin can suppress ovarian cancer …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272521/
Ivermectin, as an old anti-parasite drug, can suppress almost completely the growth of various human cancers, including ovarian cancer (OC). However …
Ivermectin as an inhibitor of cancer stem‑like cells
pubmed.ncbi.nlm.nih.gov/29257278/
The aim of the present study was to demonstrate that ivermectin preferentially inhibited cancer stem‑like cells (CSC) in breast cancer cells and …
Ivermectin: a systematic review from antiviral effects to …
pubmed.ncbi.nlm.nih.gov/32533071/
Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder …
Anti-parasite drug ivermectin can suppress ovarian cancer …
pubmed.ncbi.nlm.nih.gov/32549918/
Relevance: Ivermectin, as an old anti-parasite drug, can suppress almost completely the growth of various human cancers, including ovarian cancer …
Antitumor effects of ivermectin at clinically feasible …
pubmed.ncbi.nlm.nih.gov/32474842/
Purpose: Ivermectin is an antiparasitic drug that exhibits antitumor effects in preclinical studies, and as such is currently being repositioned for c …
Meta-analysis of Randomized Trials of Ivermectin to Treat …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420640/
Ivermectin’s broad-spectrum antiviral effects have been proposed to be related to its impact on the NF-κB pathway and via binding to the host cell …
The river blindness drug Ivermectin and related …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287931/
Ivermectin inhibits lung cancer xenograft growthin vivo. Beyond colon cancer, WNT-TCF signaling has been implicated in a number of other tumor types …
Ivermectin induces apoptosis of esophageal squamous cell …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650430/
Taken together, these data suggest that ivermectin inhibits the growth of esophageal cancer both in vitro and in vivo. It had been reported that iverm …
Antibiotic ivermectin preferentially targets renal cancer …
pubmed.ncbi.nlm.nih.gov/28847725/
Renal cell carcinoma (RCC) is the most aggressive type of genitourinary cancer and highly resistant to current available therapies. In this work, we …
Safety of inhaled ivermectin as a repurposed direct drug …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299187/
Ivermectin is a mysterious multifaceted ‘wonder’ drug that keeps shocking and exceeding expectations . It was repositioned as cancer drug , and showed …
Ivermectin inactivates the kinase PAK1 and blocks the PAK1 …
pubmed.ncbi.nlm.nih.gov/22495656/
Interestingly, several years ago it was reported by a Russian group that Ivermectin can suppress almost completely the growth of human melanoma and a …
National Cancer Institute
http://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivermectin
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry …
Ivermectin converts cold tumors hot and synergizes with …
pubmed.ncbi.nlm.nih.gov/33654071/
We show that treatment with the FDA-approved anti-parasitic drug ivermectin induces immunogenic cancer cell death (ICD) and robust T cell infiltration …
The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498772/
The docking result showed that paritaprevir and ivermectin have highest binding affinity to the ACE2 receptor with interaction energies of −11.8 kcal …
bionlp.nlm.nih.gov
bionlp.nlm.nih.gov/trec2017precisionmedicine/extra_abstracts_web/AACR_2017/AACR_2017-411.html
Epithelial ovarian cancer (EOC) is a most lethal cancer in gynecology, of which cure rate is 30%. To seek its new therapeutic targets, we performed in …
CanMED: HCPCS – seer.cancer.gov
seer.cancer.gov/oncologytoolbox/canmed/hcpcs/?s=%E2%A1%88%E2%A7%BB%20Buy%20Ivermectin%20on%20%F0%9F%90%8D%20www.PillnHeals.store%20%F0%9F%90%8D%20-%20Cheap%20Alternative%20tabs%20%E2%A7%BB%E2%A1%88%20Ivermectin%20Pour%20On%20For%20Sale
The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. Search SEER: Menu. Home. Cancer …
The second list covers Ivermectin as a universal treatment, and COVID-19 in particular (source: https://search.nih.gov/search?affiliate=nih&query=ivermectin )
Ivermectin | COVID-19 Treatment Guidelines
http://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Ivermectin is a Food and Drug Administration (FDA)-approved antiparasitic drug that is used to treat several neglected tropical diseases, including …
A five-day course of ivermectin for the treatment of COVID …
pubmed.ncbi.nlm.nih.gov/33278625/
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 …
Ivermectin for Prevention and Treatment of COVID-19 …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248252/
Ivermectin is not a new and experimental drug with an unknown safety profile. It is a WHO “Essential Medicine” already used in several different …
Ivermectin, a potential anticancer drug derived from an …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
Ivermectin is a macrolide antiparasitic drug with a 16-membered ring that is widely used for the treatment of many parasitic diseases such as river …
Ivermectin, ‘Wonder drug’ from Japan: the human use …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/
Ivermectin proved to be virtually purpose-built to combat Onchocerciasis, which has two main manifestations, dermal damage resulting from …
Ivermectin Tablets USP, 3mg (IVERMECTIN)
dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=847a1dd7-d65b-4a0e-a67d-d90392059dac
Microbiology. Ivermectin is a member of the avermectin class of broad-spectrum antiparasitic agents which have a unique mode of action. Compounds of …
Ivermectin: a systematic review from antiviral effects to …
pubmed.ncbi.nlm.nih.gov/32533071/
Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder …
Effects of Ivermectin in Patients With COVID-19: A …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101859/
Ivermectin has been suggested as a potential COVID-19 treatment.6 It is a US Food and Drug Administration (FDA)-approved broad-spectrum antiparasitic …
Review of the Emerging Evidence Demonstrating the Efficacy …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823/
Ivermectin hastens recovery and prevents deterioration in patients with mild to moderate disease treated early after symptoms. 45,49–52,61,62. Ivermec …
Protocol: Effectiveness and safety of ivermectin in the …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450968/
Ivermectin is an anti-parasitic agent that causes tonic paralysis of the muscles, thereby inducing the death of the parasite, along with …
Ivermectin in COVID-19 Management: What is the current …
pubmed.ncbi.nlm.nih.gov/35043770/
Ivermectin (IVM), an approved anthelminthic drug, has been reported to have antiviral, antibacterial, and anticancer activities. Antiviral activity is …
Ivermectin: an award-winning drug with expected antiviral …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539925/
Ivermectin is an FDA-approved broad-spectrum antiparasitic agent with demonstrated antiviral activity against a number of DNA and RNA viruses …
Repurposing the drug, ivermectin, in COVID-19 …
pubmed.ncbi.nlm.nih.gov/35123559/
The most recommended dose of ivermectin for the treatment of COVID-19 is 150-200 µg/kg twice daily. As ivermectin adoption for COVID-19 increased, the …
Serious Neurological Adverse Events after Ivermectin—Do …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929173/
INTRODUCTION. Ivermectin is a member of the class of avermectins, which are highly active broad-spectrum, anti-parasitic agents. It is indicated for …
Ivermectin: a multifaceted drug of Nobel prize-honoured …
pubmed.ncbi.nlm.nih.gov/34466270/
In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the …
Table: Ivermectin Clinical Data | COVID-19 Treatment …
http://www.covid19treatmentguidelines.nih.gov/tables/ivermectin-data/
The use of compassionate ivermectin in the management of symptomatic outpatients and hospitalized patients with clinical diagnosis of COVID-19 at the …
Use of Ivermectin Is Associated With Lower Mortality in …
pubmed.ncbi.nlm.nih.gov/33065103/
Background: Ivermectin was shown to inhibit severe acute respiratory syndrome coronavirus 2 replication in vitro, which has led to off-label use, but …
Clinical Profile and Outcome of Hemodialysis Patients with …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597802/
Over the two months, treatment protocols changed with gathering evidence. Patients received hydroxychloroquine (50%), azithromycin (63%), oseltamivir …
Endemicity of onchocerciasis in some local government …
pubmed.ncbi.nlm.nih.gov/15490791/
The established method of justifying the need for ivermectin delivery to a community is the use of Rapid Assessment Method (RAM). This method involves …
Ivermectin: a multifaceted drug of Nobel prize-honoured …
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383101/
Introduction. The 2015 Nobel prize for the discovery of ivermectin (IVM) and an antimalarial treatment was the Nobel committee’s first award for …
But they say how dangerous and deadly Ivermectin and HCQ are. The truth is quite different. Here are somd statistics
The headlines say it all. These are the results so far of adverse reactions to various medications and vaccines according to the official VAERS reporting, which give low estimates. The truth is worse. This is from Sen John Johnson:
It should be noted that for the first five medications the time frame is nearly 16 years, the result for COVID vaccine is one year.
Time to approve Ivermectin against COVID-19. It is my opinion that about 80% of all Covid deaths could have been avoided had we followed the real scientists rather than the political views of NIH.
Len Bilén's blog, a blog about faith, politics and the environment. 